Bayesian optimal interval design for dose finding in drug-combination trials.
about
Identifying a maximum tolerated contour in two-dimensional dose finding.Practical designs for Phase I combination studies in oncologyBayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology Trials.STEIN: A simple toxicity and efficacy interval design for seamless phase I/II clinical trials.Nonparametric overdose control with late-onset toxicity in phase I clinical trials.Design considerations for early-phase clinical trials of immune-oncology agentsTime-to-Event Bayesian Optimal Interval Design to Accelerate Phase I Trials
P2860
Q30277277-F403FCC6-2ED3-44E4-931D-8032BBA3F504Q30278669-34F42557-5CF4-4B3A-A300-463658AFDF92Q41282610-8284765E-5CAC-421E-8B89-A499C640261AQ48275752-A3E47D2D-0443-4EFA-B640-B411480929E2Q50593013-107EEB10-9A86-4FD7-BDA3-C28726B64323Q56334001-4BA35EA3-502F-42B6-A57A-56AC30862B76Q57462262-7C6CDB1C-7BDD-41FE-822D-DB208406BBDC
P2860
Bayesian optimal interval design for dose finding in drug-combination trials.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Bayesian optimal interval design for dose finding in drug-combination trials.
@en
type
label
Bayesian optimal interval design for dose finding in drug-combination trials.
@en
prefLabel
Bayesian optimal interval design for dose finding in drug-combination trials.
@en
P2860
P356
P1476
Bayesian optimal interval design for dose finding in drug-combination trials.
@en
P2093
Guosheng Yin
P2860
P304
P356
10.1177/0962280215594494
P50
P577
2015-07-15T00:00:00Z